117 related articles for article (PubMed ID: 24947354)
1. Neuroretinal dysfunction with intact blood-retinal barrier and absent vasculopathy in type 1 diabetes.
Reis A; Mateus C; Melo P; Figueira J; Cunha-Vaz J; Castelo-Branco M
Diabetes; 2014 Nov; 63(11):3926-37. PubMed ID: 24947354
[TBL] [Abstract][Full Text] [Related]
2. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy.
Fortune B; Schneck ME; Adams AJ
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2638-51. PubMed ID: 10509661
[TBL] [Abstract][Full Text] [Related]
3. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
4. Permeability of the blood-retinal barrier and the blood-aqueous barrier in type I diabetes without diabetic retinopathy: simultaneous evaluation with fluorophotometry.
Schalnus R; Ohrloff C; Jungmann E; Maass K; Rinke S; Wagner A
Ger J Ophthalmol; 1993 Aug; 2(4-5):202-6. PubMed ID: 8220099
[TBL] [Abstract][Full Text] [Related]
5. [The blood-retina barrier and blood-aqueous humor barrier in type I diabetic patients without retinopathy. Determination of permeability using fluorophotometry and laser flare measurements].
Schalnus R; Ohrloff C
Klin Monbl Augenheilkd; 1993 Apr; 202(4):281-7. PubMed ID: 8331884
[TBL] [Abstract][Full Text] [Related]
6. Neuroretinal degeneration in relation to vasculopathy in diabetes.
Verbraak FD
Diabetes; 2014 Nov; 63(11):3590-2. PubMed ID: 25342732
[No Abstract] [Full Text] [Related]
7. Blood-retina barrier permeability and its relation to the progression of diabetic retinopathy in type 1 diabetics. An 8-year follow-up study.
Engler C; Krogsaa B; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):442-6. PubMed ID: 1937077
[TBL] [Abstract][Full Text] [Related]
8. Antihistamines reduce blood-retinal barrier permeability in type I (insulin-dependent) diabetic patients with nonproliferative retinopathy. A pilot study.
Gardner TW; Eller AW; Friberg TR; D'Antonio JA; Hollis TM
Retina; 1995; 15(2):134-40. PubMed ID: 7624601
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy.
Lecleire-Collet A; Audo I; Aout M; Girmens JF; Sofroni R; Erginay A; Le Gargasson JF; Mohand-Saïd S; Meas T; Guillausseau PJ; Vicaut E; Paques M; Massin P
Invest Ophthalmol Vis Sci; 2011 May; 52(6):2861-7. PubMed ID: 21282578
[TBL] [Abstract][Full Text] [Related]
10. MRI retinovascular studies in humans: research in patients with diabetes.
Trick GL; Edwards PA; Desai U; Morton PE; Latif Z; Berkowitz BA
NMR Biomed; 2008 Nov; 21(9):1003-12. PubMed ID: 18821575
[TBL] [Abstract][Full Text] [Related]
11. Protective factors in diabetic retinopathy: focus on blood-retinal barrier.
Zhang C; Wang H; Nie J; Wang F
Discov Med; 2014 Sep; 18(98):105-12. PubMed ID: 25227751
[TBL] [Abstract][Full Text] [Related]
12. Occipital blood-brain barrier permeability is an independent predictor of visual outcome in type 2 diabetes, irrespective of the retinal barrier: A longitudinal study.
Abuhaiba SI; Cordeiro M; Amorim A; Cruz Â; Quendera B; Ferreira C; Ribeiro L; Bernardes R; Castelo-Branco M
J Neuroendocrinol; 2018 Jan; 30(1):. PubMed ID: 29247551
[TBL] [Abstract][Full Text] [Related]
13. Localizing functional damage in the neural retina of adolescents and young adults with type 1 diabetes.
Tan W; Wright T; Dupuis A; Lakhani E; Westall C
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2432-41. PubMed ID: 24526434
[TBL] [Abstract][Full Text] [Related]
14. Electron microscopic immunocytochemical evidence for the mechanism of blood-retinal barrier breakdown in galactosemic rats and its association with aldose reductase expression and inhibition.
Vinores SA; Van Niel E; Swerdloff JL; Campochiaro PA
Exp Eye Res; 1993 Dec; 57(6):723-35. PubMed ID: 8150024
[TBL] [Abstract][Full Text] [Related]
15. Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction.
Tawfik A; Samra YA; Elsherbiny NM; Al-Shabrawey M
Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32751132
[TBL] [Abstract][Full Text] [Related]
16. Inner retinal visual dysfunction is a sensitive marker of non-proliferative diabetic retinopathy.
Jackson GR; Scott IU; Quillen DA; Walter LE; Gardner TW
Br J Ophthalmol; 2012 May; 96(5):699-703. PubMed ID: 22174096
[TBL] [Abstract][Full Text] [Related]
17. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits.
Alikacem N; Yoshizawa T; Nelson KD; Wilson CA
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1561-9. PubMed ID: 10798677
[TBL] [Abstract][Full Text] [Related]
18. Contribution of extracellular vesicles for the pathogenesis of retinal diseases: shedding light on blood-retinal barrier dysfunction.
Martins B; Pires M; Ambrósio AF; Girão H; Fernandes R
J Biomed Sci; 2024 May; 31(1):48. PubMed ID: 38730462
[TBL] [Abstract][Full Text] [Related]
19. Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus.
Picconi F; Mataluni G; Ziccardi L; Parravano M; Di Renzo A; Ylli D; Pasqualetti P; Studer V; Chioma L; Marfia GA; Frontoni S
J Diabetes Res; 2018; 2018():9763507. PubMed ID: 30402503
[TBL] [Abstract][Full Text] [Related]
20. [A new method in the analysis of vitreous fluorophotometry. Results in early diabetic retinopathy].
Roy MS; Bungay P; Collier B; Bonner R
Ophtalmologie; 1989; 3(3):214-6. PubMed ID: 2641114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
